COVID-19: Johnson & Johnson to test vaccine on 60,000 people

American pharmaceutical giant, Johnson & Johnson, announced that it would test 60,000 people for its coronavirus vaccine. This is larger than any other vaccine trials being conducted.

This was disclosed in an email to investors on Thursday, by the company spokesman, Jake Sargent. He said that the trial is planned to be as robust as possible. Already, planning and recruitment for the vaccine trial has begun.

The spokesman also disclosed that trials of the vaccine would be conducted in COVID-19 hot spots using modeling data.

The World Health Organization said that over 160 vaccines globally are being developed to fight COVID-19, with 30 vaccines already in human trial phase. Some companies have already received emergency approvals and finalizing deals with governments around the world for their distribution.

Johnson & Johnson said its COVID-19 human trials would begin in September.

Leave a Reply

Your email address will not be published. Required fields are marked *